Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

Monica Gerson , Benzinga Staff Writer

January 07, 2013 3:17am Comments

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash.

Salix Pharmaceuticals (NASDAQ: SLXP) had $775.90 million in total cash and $869.10 million in total debt for the latest quarter.

Mylan (NASDAQ: MYL) had $412.67 million in total cash for the latest quarter. However, Mylan had $5.37 billion in total debt for the same period.

Hi Tech Pharmacal Co (NASDAQ: HITK) had $104.09 million in total cash and $1.42 million in total debt for the latest quarter.

Akorn (NASDAQ: AKRX) had $38.40 million in total cash and $103.65 million in total debt for the latest quarter.

Posted-In: Drugs-Generic Industry highest cash NASDAQ Stocks Trading Ideas

1	TOSYY, CBI: Chicago Bridge & Iron Company Finally Gets A Catalyst To The Upside
2	WBA, RAD: Bank Of America: What To Expect For Rite Aid Ahead Of FTC Merg...
3	WHF, ALDR: 22 Stocks Moving In Tuesday's Pre-Market Session
4	LNVGY, HPE: Changing Chip Dynamics May Favor Advanced M...
5	SPNC, GMRE: 22 Stocks Moving In Wednesday...
6	AAPL: What Will Apple Look Like In...
7	BAYRY, MON: The Prospect Of The...

1	SPNC, SPLS: Wall Street's M&A Chatter From June 28: Staples, Lululemon, T...
2	EUFN, DFS: Valeant, Financials And More: Fast Money Picks For June 29
3	RAD, CAG: 10 Stocks To Watch For June 29, 2017
4	Economic Data Scheduled For Thursday
5	LNN, AOBC: Earnings Scheduled For June 29, 2017
6	MOS, FIT: Watch These 5 Huge Put Purchases In...
7	CLF, NRG: Watch These 7 Huge Call Purc...

Market Overview